(Q39300010)

10 September 2017

title

MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC). (English)

1 reference

10 September 2017

0 references

Matilda Fatunmbi

1

1 reference

10 September 2017

Justin Shelton

series ordinal

2

1 reference

10 September 2017

Susan M Aronica

series ordinal

3

1 reference

10 September 2017

language of work or name

English

0 references

publication date

10 August 2012

1 reference

Breast Cancer Research and Treatment

10 September 2017

published in

1 reference

10 September 2017

volume

135

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

519-530

1 reference

Cancer as an evolutionary and ecological process

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Role of HER2/neu in tumor progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Dysregulation of cellular signaling by HER2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

A positive role for PEA3 in HER2-mediated breast tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

What is the difference between triple-negative and basal breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2191-5

10.1007/S10549-012-2191-5

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference